Disc Medicine Stock News & Updates
[WKN: A3D063 | Symbol: IRON]
Disc Medicine (IRON) in Pivotal Point Check: FDA Submission Following Phase 3 Data on Bitopertin and 350 Million USD Placement Secures Market Entry 2027!
Study Success as a Price Driver: Achieving all primary and secondary endpoints in the pivotal Phase...
Stocks in Action USA: Cleveland-Cliffs, Disc Medicine, Applied Digital
Applied Digital (APLD) – Insider Purchases Over $6.6 Million: Does the AI Infrastructure Boom Provide...
Pivotal-Point Tracking Disc Medicine (IRON): FDA Priority Voucher Accelerates Bitopertin!
Disc Medicine is a clinical biotechnology company focused on the discovery, development, and commercialization...
Disc Medicine Inc. (IRON): H.C. Wainwright Sees 116% Price Potential - Bitopertin Could Prevent Liver Damage in EPP Patients
Disc Medicine Inc. (IRON) is a clinical-stage biopharmaceutical company dedicated to the discovery,...
Analysts' Top 5 Price Targets of July 4, 2025
Rational AG [DE0007010803]: Bernstein reiterates Buy rating and adjusts the price target from €970...
- ‹
- 1
- ›